OpenAlex
PricingAboutJobs
Log inGet started
Work

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

HTML

Year: 2013
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-13-0755
Authors: Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas, Robert C. Kane, Kallappa M. Koti, Mark D. Rothmann, Bahru Habtemariam, Julie Bullock, Jeffrey D. Bray, Jessica Hawes, Todd R. Palmby, Josephine Jee, William Adams, Houda Mahayni, Janice Brown, Angelica Dorantes, Rajeshwari Sridhara, Ann T. Farrell, Richard Pazdur
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Frederick National Laboratory for Cancer Research, National Cancer Institute
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: carfilzomib, multiple myeloma, accelerated FDA approval, proteasome inhibitors, bortezomib-refractory disease, immunomodulators, overall response rate, drug safety, adverse events, infusion reactions, dexamethasone pretreatment
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2071430789
FWCI: 16.7
Cites: 18
Cited by: 265
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms